Applied Materials
AMAT
408.12
-4.99
-1.21%
Applied Materials
US · AMAT
#40 by market cap
Listed 1978
408.12
-4.99
-1.21%
Live - 5344 symbols - heartbeat 17s ago
· 2026-10-20 11:00
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 16.34, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +4.39% YoY
Margins
- Gross margin
- 48.67%
- Operating margin
- 29.86%
- Net margin
- 24.67%
Key ratios & quality
- Enterprise valuei
- 321.96B
- PEG ratioi
- 14.92
- Altman Z-Scorei
- 16.34
PEG uses trailing P/E against the 3-year net income growth rate (2.36%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 16.71B | 14.61B | 17.20B | 23.06B | 25.79B | 26.52B | 27.18B | 28.37B |
| Gross profit | 7.52B | 6.39B | 7.69B | 10.91B | 11.99B | 12.38B | 12.90B | 13.81B |
| Selling & admin expenses | 1.00B | 982.00M | 1.09B | 1.23B | 1.44B | 1.63B | 1.80B | 1.77B |
| Research & development | 2.02B | 2.05B | 2.23B | 2.49B | 2.77B | 3.10B | 3.23B | 3.57B |
| Operating profit | 4.49B | 3.35B | 4.37B | 7.20B | 7.78B | 7.65B | 7.87B | 8.47B |
| Pretax profit | 4.40B | 3.27B | 4.17B | 6.77B | 7.60B | 7.72B | 8.15B | 9.27B |
| Tax | 1.36B | 563.00M | 547.00M | 883.00M | 1.07B | 860.00M | 975.00M | 2.27B |
| Net profit | 3.04B | 2.71B | 3.62B | 5.89B | 6.53B | 6.86B | 7.18B | 7.00B |
| Basic EPS | 3 | 3 | 4 | 6 | 7 | 8 | 9 | 9 |
| Diluted EPS | 2.96 | 2.86 | 3.92 | 6.40 | 7.44 | 8.11 | 8.61 | 8.66 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 7.10B | 7.30B | 6.80B | 7.01B | 7.91B | 9.12B |
| Gross profit | 3.49B | 3.56B | 3.27B | 3.44B | 3.95B | 4.59B |
| Selling & admin expenses | 423.00M | 428.00M | 455.00M | 411.00M | 397.00M | 411.00M |
| Research & development | 893.00M | 901.00M | 917.00M | 928.00M | 1.03B | 1.10B |
| Operating profit | 2.17B | 2.23B | 1.89B | 2.10B | 2.52B | 3.08B |
| Pretax profit | 2.32B | 2.56B | 2.27B | 2.33B | 3.23B | 2.91B |
| Tax | 185.00M | 784.00M | 370.00M | 302.00M | 419.00M | 369.00M |
| Net profit | 2.14B | 1.78B | 1.90B | 2.03B | 2.81B | 2.54B |
| Basic EPS | 3 | 2 | 2 | 3 | 4 | 3 |
| Diluted EPS | 2.63 | 2.22 | 2.38 | 2.54 | 3.51 | 3.17 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 10.60B | 10.21B | 13.37B | 16.11B | 15.93B | 19.15B | 21.22B | 20.88B |
| Cash & ST investments | 4.03B | 3.62B | 5.74B | 5.46B | 2.58B | 6.87B | 9.47B | 8.57B |
| Inventory | 3.72B | 3.47B | 3.90B | 4.31B | 5.93B | 5.73B | 5.42B | 5.92B |
| Total assets | 17.63B | 19.02B | 22.35B | 25.83B | 26.73B | 30.73B | 34.41B | 36.30B |
| Total current liabilities | 3.92B | 4.45B | 4.46B | 6.34B | 7.38B | 7.37B | 8.47B | 8.00B |
| Short-term debt | -- | 600.00M | 64.00M | 73.00M | 85.00M | 286.00M | 887.00M | 191.00M |
| Long-term debt | 5.31B | 4.71B | 5.45B | 5.45B | 5.46B | 5.46B | 5.46B | 6.46B |
| Total liabilities | 10,788,000,000.00 | 10,810,000,000.00 | 11,775,000,000.00 | 13,578,000,000.00 | 14,532,000,000.00 | 14,380,000,000.00 | 15,408,000,000.00 | 15,884,000,000.00 |
| Total equity | 6.85B | 8.21B | 10.58B | 12.25B | 12.19B | 16.35B | 19.00B | 20.42B |
| Retained earnings | 20.88B | 24.39B | 27.21B | 32.25B | 37.89B | 43.73B | 49.65B | 55.23B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 19.71B | 19.72B | 20.88B | 21.05B | 22.57B | 25.10B |
| Cash & ST investments | 6.75B | 7.01B | 8.57B | 8.51B | 8.24B | 9.23B |
| Inventory | 5.66B | 5.81B | 5.92B | 6.00B | 6.34B | 6.56B |
| Total assets | 33.63B | 34.21B | 36.30B | 37.64B | 40.29B | 43.52B |
| Total current liabilities | 8.00B | 7.88B | 8.00B | 7.75B | 9.00B | 10.36B |
| Short-term debt | 880.00M | 888.00M | 191.00M | 201.00M | 1.31B | 1.42B |
| Long-term debt | 5.46B | 5.46B | 6.46B | 6.45B | 5.26B | 5.25B |
| Total liabilities | 14,671,000,000.00 | 14,707,000,000.00 | 15,884,000,000.00 | 15,927,000,000.00 | 16,377,000,000.00 | 17,896,000,000.00 |
| Total equity | 18.96B | 19.50B | 20.42B | 21.72B | 23.91B | 25.63B |
| Retained earnings | 52.28B | 53.69B | 55.23B | 56.89B | 59.27B | 61.39B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 3.79B | 3.25B | 3.80B | 5.44B | 5.40B | 8.70B | 8.68B | 7.96B |
| Depreciation & amortization | 457.00M | 363.00M | 376.00M | 394.00M | 444.00M | 515.00M | 392.00M | 435.00M |
| Free cash flow | 3.17B | 2.81B | 3.38B | 4.77B | 4.61B | 7.59B | 7.49B | 5.70B |
| Dividends paid | -605.00M | -771.00M | -787.00M | -838.00M | -873.00M | -975.00M | -1.19B | -1.38B |
| Stock buybacks / issuance | -5.16B | -2.26B | -475.00M | -3.58B | -5.90B | -1.96B | -3.58B | -4.63B |
| Ending cash balance | 3.44B | 3.13B | 5.47B | 5.10B | 2.10B | 6.23B | 8.11B | 7.31B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.57B | 2.63B | 2.83B | 1.69B | 845.00M | 3.04B |
| Depreciation & amortization | 103.00M | 113.00M | 114.00M | 127.00M | 135.00M | 151.00M |
| Free cash flow | 1.06B | 2.05B | 2.04B | 1.04B | 210.00M | 2.33B |
| Dividends paid | -325.00M | -368.00M | -365.00M | -365.00M | -365.00M | -420.00M |
| Stock buybacks / issuance | -1.54B | -1.06B | -719.00M | -337.00M | -269.00M | -440.00M |
| Ending cash balance | 6.24B | 5.45B | 7.31B | 7.29B | 6.36B | 7.09B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 40.93 | 35.95 | 38.52 | 51.59 | 53.39 | 48.04 | 40.61 | 35.51 |
| ROA %i | 17.82 | 14.71 | 17.49 | 24.44 | 24.83 | 23.87 | 22.04 | 19.79 |
| ROIC %i | 25.26 | 21.11 | 25.44 | 34.95 | 37.13 | 33.69 | 28.89 | 23.58 |
| 5-year avg ROE %i | 27.07 | 31.39 | 35.53 | 41.21 | 43.39 | 45.50 | 46.43 | 45.83 |
| EBIT margin %i | 28.56 | 24.00 | 25.61 | 30.38 | 30.35 | 30.00 | 30.91 | 33.63 |
| FCF / sales %i | 18.34 | 19.21 | 19.66 | 20.70 | 17.89 | 28.64 | 27.55 | 20.09 |
| Current ratioi | 2.70 | 2.30 | 3.00 | 2.54 | 2.16 | 2.60 | 2.51 | 2.61 |
| Quick ratioi | 1.63 | 1.40 | 1.99 | 1.73 | 1.23 | 1.69 | 1.75 | 1.74 |
| Debt / assetsi | 30.11 | 27.93 | 25.53 | 22.28 | 21.81 | 19.52 | 19.20 | 19.42 |
| LT debt / equityi | 77.56 | 57.38 | 53.35 | 46.38 | 47.11 | 34.94 | 30.10 | 33.60 |
| Interest coveragei | 21.06 | 14.79 | 18.36 | 29.69 | 34.33 | 33.42 | 34.00 | 35.46 |
| Revenue CAGR (3Y) %i | 20.03 | 10.51 | 5.38 | 11.35 | 20.85 | 15.52 | 5.62 | 3.23 |
| Net income CAGR (3Y) %i | 30.18 | 16.28 | 0.94 | 24.68 | 34.10 | 23.74 | 6.82 | 2.36 |
| FCF CAGR (3Y) %i | 49.46 | 6.65 | -0.60 | 14.68 | 18.01 | 30.95 | 16.18 | 7.30 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 36.37 | 35.64 | 35.51 | 38.86 | 39.69 | 41.07 |
| ROA %i | 20.61 | 20.14 | 19.79 | 22.09 | 23.02 | 23.84 |
| ROIC %i | 27.24 | 25.57 | 23.58 | 24.28 | 23.94 | 26.66 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 30.46 | 32.02 | 33.63 | 34.57 | 36.72 | 35.68 |
| FCF / sales %i | 20.87 | 20.35 | 20.09 | 21.95 | 18.41 | 18.23 |
| Current ratioi | 2.46 | 2.50 | 2.61 | 2.71 | 2.51 | 2.42 |
| Quick ratioi | 1.62 | 1.63 | 1.74 | 1.81 | 1.67 | 1.67 |
| Debt / assetsi | 19.83 | 19.77 | 19.42 | 19.10 | 18.04 | 16.88 |
| LT debt / equityi | 30.54 | 30.12 | 33.60 | 32.18 | 24.91 | 23.13 |
| Interest coveragei | 32.79 | 34.71 | 35.46 | 35.60 | 38.76 | 39.73 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Semiconductor Systems is the largest reported line at 77.24% of revenue, across 3 reported segments.
- The next-largest line, Applied Global Services, is a distant second at 19.54% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Semiconductor Systems77.24%
Applied Global Services19.54%
Other3.23%
Quote time 2026-10-20 11:00:15 · For reference only, not investment advice and not tailored to your situation.
china exposure is the risk everyone brings up but the order book outside china looks healthy on its own. equipment names always lag the chip names at turns, worth remembering that.